SCHEMBL21494724

SCHEMBL21494724

Nc1nc(N)c(CC(=O)Nc2ccc(C(=O)NC(Cc3ccccc3)C(=O)O)nc2)c(=O)[nH]1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ FPR2 P25090 18/20 1.00
▸ AKR1B1 P15121 2/20 0.57
▸ MTHFD1 P11586 1/20 0.55
▸ MTHFD2 P13995 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30106813 1.00 FPR2 (1.00) FPR2AKR1B1MTHFD1MTHFD2
SCHEMBL21494723 1.00 FPR2 (1.00) FPR2AKR1B1MTHFD1MTHFD2
SCHEMBL21494675 0.87 FPR2 (1.00) FPR2MTHFD1MTHFD2
SCHEMBL31657846 0.87 FPR2 (1.00) FPR2MTHFD1MTHFD2
SCHEMBL21494679 0.87 FPR2 (1.00) FPR2MTHFD1MTHFD2
Hydrochloric Acid SCHEMBL23005183 0.86 FPR2 (0.98) FPR2MTHFD1MTHFD2
Hydrochloric Acid SCHEMBL30106783 0.86 FPR2 (0.98) FPR2MTHFD1MTHFD2
Hydrochloric Acid SCHEMBL23005184 0.86 FPR2 (0.98) FPR2MTHFD1MTHFD2
Hydrochloric Acid SCHEMBL21494810 0.86 FPR2 (0.98) FPR2MTHFD1MTHFD2
SCHEMBL21494607 0.85 FPR2 (1.00) FPR2AKR1B1MTHFD1MTHFD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3781554-A1 2,6-DIAMINO-3,4-DIHYDROPYRIMIDIN-4-ONE DERIVATIVES AND USE THEREOF IN THERAPY Thomas Helledays stiftelse för medicinsk forskning (SE) 2021-02-24 — — EP claimed
WO-2019201991-A1 2,6-DIAMINO-3,4-DIHYDROPYRIMIDIN-4-ONE DERIVATIVES AND USE THEREOF IN THERAPY THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING (SE) 2019-10-24 — — WO claimed
EP-3781554-B1 2,6-DIAMINO-3,4-DIHYDROPYRIMIDIN-4-ONE DERIVATIVES AND USE THEREOF IN THERAPY THOMAS HELLEDAYS STIFTELSE FOER MEDICINSK FORSKNING (SE) 2023-06-28 — — EP disclosed
Send feedback